High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade During Ibrutinib Therapy in Patients with CLL.

• Authors: CHIODIN G.; DUTTON D.; MARTINO EA.; DRENNAN S.; TRACY I.; ONDRIŠOVÁ Laura; HENDERSON I.; D´AVOLA A.; PITSILLIDOU Ch.; MRÁZ Marek; JOHNSON P.; DUNCOMBE A.; PACKHAM G.; STEELE A.; PARKER H.; BONFIGLIO S.; SCARFO L.; SUTTON LA.; GHIA P.; ROSE-ZERILLI MJJ.; STREFFORD J.; STEVENSON F.; FORCONI F.
• Year of publication: 2019
• Type: Conference abstract
• MU Faculty or unit: Central European Institute of Technology